180 related articles for article (PubMed ID: 29131134)
1. Mannose-Binding Lectin Does Not Act as a Biomarker for the Progression of Preinvasive Lesions of Invasive Cervical Cancer.
Maestri CA; Nisihara R; Ramos GP; Weinschutz Mendes H; Messias-Reason I; de Carvalho NS
Med Princ Pract; 2017; 26(6):530-534. PubMed ID: 29131134
[TBL] [Abstract][Full Text] [Related]
2. MBL serum concentration in women with HPV presenting CIN III lesions.
Ramos GP; Nisihara R; Maestri CA; Bicalho MG; Carvalho NS; de Messias Reason I
Hum Immunol; 2013 Jan; 74(1):67-9. PubMed ID: 23017671
[TBL] [Abstract][Full Text] [Related]
3. MASP-1 and MASP-2 Serum Levels Are Associated With Worse Prognostic in Cervical Cancer Progression.
Maestri CA; Nisihara R; Mendes HW; Jensenius J; Thiel S; Messias-Reason I; de Carvalho NS
Front Immunol; 2018; 9():2742. PubMed ID: 30532757
[No Abstract] [Full Text] [Related]
4. HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level.
Berlin Grace VM; Niranjali Devaraj S; Radhakrishnan Pillai M; Devaraj H
Gynecol Oncol; 2006 Oct; 103(1):113-9. PubMed ID: 16554086
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study on cervical intraepithelial neoplasia with high-risk HPV infection among pregnant women].
He Y; Wu YM; Wang T; Song F; Wang Y; Zhao Q; Kong WM; Duan W; Zhu L; Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):598-602. PubMed ID: 23141180
[TBL] [Abstract][Full Text] [Related]
6. Antinuclear antibodies in patients with cervical lesions and invasive cervical cancer.
Skare TL; Neppel A; Machoski MCC; Maestri CA; Messias-Reason I; Nisihara R
Immunol Lett; 2019 Apr; 208():8-10. PubMed ID: 30849399
[TBL] [Abstract][Full Text] [Related]
7. Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion.
Ryu KJ; Lee S; Min KJ; Kim JW; Hong JH; Song JY; Lee JK; Lee NW
Oncologist; 2015 Jun; 20(6):635-9. PubMed ID: 25964305
[TBL] [Abstract][Full Text] [Related]
8. Detection of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cancer patients: Sharkia Governorate, Egypt.
Abd El-Azim S; Lotfy M; Omr A
Clin Lab; 2011; 57(5-6):363-71. PubMed ID: 21755827
[TBL] [Abstract][Full Text] [Related]
9. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
Wang R; Li X; Qian M; Niu J; You Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
[TBL] [Abstract][Full Text] [Related]
10. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.
Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B
Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553
[TBL] [Abstract][Full Text] [Related]
11. Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions.
Barbosa LC; da Silva ID; Corrêa JC; Ribalta JC
Int J Gynecol Cancer; 2011 Jan; 21(1):15-21. PubMed ID: 21330827
[TBL] [Abstract][Full Text] [Related]
12. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
13. Serum micronutrients and cervical dysplasia in Southwestern American Indian women.
Yeo AS; Schiff MA; Montoya G; Masuk M; van Asselt-King L; Becker TM
Nutr Cancer; 2000; 38(2):141-50. PubMed ID: 11525590
[TBL] [Abstract][Full Text] [Related]
14. Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions.
Li K; Yin R
Medicine (Baltimore); 2015 Feb; 94(5):e435. PubMed ID: 25654377
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus investigation of patients with cervical intraepithelial neoplasia 3, some of whom progressed to invasive cancer.
Shah KV; Kessis TD; Shah F; Gupta JW; Shibata D; Jones RW
Int J Gynecol Pathol; 1996 Apr; 15(2):127-30. PubMed ID: 8786201
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Katki H; Cheung L; Wacholder S; Burk RD
J Natl Cancer Inst; 2010 Mar; 102(5):315-24. PubMed ID: 20157096
[TBL] [Abstract][Full Text] [Related]
17. Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.
Kim CJ; Lee YS; Kwack HS; Yoon WS; Park TC; Park JS
Int J Gynecol Cancer; 2010 Aug; 20(6):1067-73. PubMed ID: 20683419
[TBL] [Abstract][Full Text] [Related]
18. [Investigation on the prevalence of high risk human papillomavirus and cervical cancer among adult women, in Shenzhen].
DU H; Wu RF; Tang HR; Wu LN; Zhang LJ; Liu ZH; Li J; Li RZ; Wang GP; Zhou YQ; Wang C; Weng LM
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):799-802. PubMed ID: 22967332
[TBL] [Abstract][Full Text] [Related]
19. Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients.
Ho CM; Yang SS; Chien TY; Huang SH; Jeng CJ; Chang SF
Gynecol Oncol; 2005 Dec; 99(3):615-21. PubMed ID: 16099020
[TBL] [Abstract][Full Text] [Related]
20. The meaning of high-risk HPV other than type 16/18 in women with negative cytology: Is it really safe to wait for 1 year?
Kabaca C; Giray B; Guray Uzun M; Akis S; Purut YE; Keles Peker E; Cetiner H; Bostanci Ergen E
Diagn Cytopathol; 2021 Apr; 49(4):480-486. PubMed ID: 33528903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
